Last 12 months
Inside the activity.
1 purchase rows · 142 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 48 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 24 |
| Jun 2026 | 1 | 26 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
SaleCOMMON STOCK | 201 | $79.21 | $15,921.21 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 8 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,052 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · shares: Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.17 to $79.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
SaleCOMMON STOCK | 21,176 | $78.78 | $1,668,245.28 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 7 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,253 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · shares: Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.17 to $79.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
SaleCOMMON STOCK | 4,629 | $77.81 | $360,182.49 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 6 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,429 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · shares: Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.13 to $78.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
SaleCOMMON STOCK | 1,045 | $76.85 | $80,308.25 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 5 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,058 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · shares: Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.13 to $77.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
Exercise / conversionCOMMON STOCK | 26,782 | $4.18 | $111,948.76 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 4 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 18:27 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 10,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001628280-19-014428 · wf-form4_157437884288796.xml · derivative · entry 6 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,833 Underlying: COMMON STOCK · 10,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 18:27 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 300 | $79.42 | $23,826.00 |
DisclosureSEC source: 0001628280-19-014428 · wf-form4_157437884288796.xml · nonDerivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $79.42 to $79.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 18:27 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,870 | $78.85 | $383,999.50 |
DisclosureSEC source: 0001628280-19-014428 · wf-form4_157437884288796.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,602 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.34 to $79.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 18:27 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 600 | $77.89 | $46,734.00 |
DisclosureSEC source: 0001628280-19-014428 · wf-form4_157437884288796.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,472 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.30 to $78.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 18:27 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,230 | $76.91 | $325,329.30 |
DisclosureSEC source: 0001628280-19-014428 · wf-form4_157437884288796.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,072 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $76.30 to $77.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2019 Filed Nov 21, 2019 18:27 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 10,000 | $5.94 | $59,400.00 |
DisclosureSEC source: 0001628280-19-014428 · wf-form4_157437884288796.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:56 UTC |
BERTOCCI DEREK AChief Financial Officer
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 10,759 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001628280-19-014367 · wf-form4_157429055431721.xml · derivative · entry 6 BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,131 Underlying: COMMON STOCK · 10,759 shares Expires 2028-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:56 UTC |
BERTOCCI DEREK AChief Financial Officer
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 14,722 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001628280-19-014367 · wf-form4_157429055431721.xml · derivative · entry 5 BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,742 Underlying: COMMON STOCK · 14,722 shares Expires 2026-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the options on July 18, 2017, thereafter vests in equal monthly installments over 36 months. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:56 UTC |
BERTOCCI DEREK AChief Financial Officer
|
SaleCOMMON STOCK | 12,936 | $79.90 | $1,033,586.40 |
DisclosureSEC source: 0001628280-19-014367 · wf-form4_157429055431721.xml · nonDerivative · entry 4 BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,962 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $3.63 or $8.80 per share. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.68 to $80.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:56 UTC |
BERTOCCI DEREK AChief Financial Officer
|
SaleCOMMON STOCK | 12,545 | $79.25 | $994,191.25 |
DisclosureSEC source: 0001628280-19-014367 · wf-form4_157429055431721.xml · nonDerivative · entry 3 BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,898 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $3.63 or $8.80 per share. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.66 to $79.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:56 UTC |
BERTOCCI DEREK AChief Financial Officer
|
Exercise / conversionCOMMON STOCK | 10,759 | $8.80 | $94,679.20 |
DisclosureSEC source: 0001628280-19-014367 · wf-form4_157429055431721.xml · nonDerivative · entry 2 BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:56 UTC |
BERTOCCI DEREK AChief Financial Officer
|
Exercise / conversionCOMMON STOCK | 14,722 | $3.63 | $53,440.86 |
DisclosureSEC source: 0001628280-19-014367 · wf-form4_157429055431721.xml · nonDerivative · entry 1 BERTOCCI DEREK A · CIK 0001206964 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 17:37 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 10,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001628280-19-014246 · wf-form4_157377102596136.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,833 Underlying: COMMON STOCK · 10,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 17:37 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 10,000 | $70.97 | $709,700.00 |
DisclosureSEC source: 0001628280-19-014246 · wf-form4_157377102596136.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.55 to $71.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 17:37 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 10,000 | $5.94 | $59,400.00 |
DisclosureSEC source: 0001628280-19-014246 · wf-form4_157377102596136.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 16:53 UTC |
Wiley Michael JChief Legal Officer
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 6,779 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001628280-19-014124 · wf-form4_157368201395771.xml · derivative · entry 9 Wiley Michael J · CIK 0001753789 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,781 Underlying: COMMON STOCK · 6,779 shares Expires 2027-07-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 16:53 UTC |
Wiley Michael JChief Legal Officer
|
SaleCOMMON STOCK | 3,881 | $73.08 | $283,623.48 |
DisclosureSEC source: 0001628280-19-014124 · wf-form4_157368201395771.xml · nonDerivative · entry 8 Wiley Michael J · CIK 0001753789 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,737 F2 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.72 to $73.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 16:53 UTC |
Wiley Michael JChief Legal Officer
|
SaleCOMMON STOCK | 2,898 | $72.12 | $209,003.76 |
DisclosureSEC source: 0001628280-19-014124 · wf-form4_157368201395771.xml · nonDerivative · entry 7 Wiley Michael J · CIK 0001753789 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,618 F2 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.71 to $72.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 16:53 UTC |
Wiley Michael JChief Legal Officer
|
Exercise / conversionCOMMON STOCK | 6,779 | $4.18 | $28,336.22 |
DisclosureSEC source: 0001628280-19-014124 · wf-form4_157368201395771.xml · nonDerivative · entry 6 Wiley Michael J · CIK 0001753789 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 11, 2019 Filed Nov 13, 2019 17:14 UTC |
Kaul SamirDirector
|
OtherCOMMON STOCK | 54,845 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-014132 · wf-form4_157368327237310.xml · nonDerivative · entry 2 Kaul Samir · CIK 0001501915 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 56,250 F2 · kind: On November 11, 2019, shares of Common Stock of the Issuer held by Khosla Ventures Associates IV, LLC were distributed to its underlying partners and members. As part of such distributions, Mr. Kaul received 54,845 shares of the Issuer's Common Stock. F1 · ownership.nature: Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family. Read SEC document |
| November 07, 2019 Filed Feb 11, 2020 21:12 UTC Amendment |
Eltoukhy HelmyDirector · Chief Executive Officer
|
GiftCOMMON STOCK | 1,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-20-001352 · wf-form5a_158145555186866.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,474,981 F1 · ownership.direct: Ownership as of December 31, 2019. F2 · ownership.direct: The Reporting Person does not serve as a trustee or exercise any control over the securities held by the Genevieve Eltoukhy 2018 Irrevocable Trust, the Isabella Eltoukhy 2018 Irrevocable Trust or the Camille Eltoukhy 2018 Irrevocable Trust, and thus, the Reporting Person is not deemed to indirectly hold such securities. Read SEC document |
| November 06, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
GiftCOMMON STOCK | 451 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 3 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Shares held by Sana Talasaz 2018 Irrevocable Trust Disclosed balance after: 9,974 Read SEC document |
| November 06, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
GiftCOMMON STOCK | 451 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 2 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Indirect · Shares held by Samar Talasaz 2018 Irrevocable Trust Disclosed balance after: 9,974 Read SEC document |
| November 06, 2019 Filed Nov 21, 2019 23:30 UTC |
Talasaz AmirAliDirector · Chairman, President and COO
|
GiftCOMMON STOCK | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-19-014431 · wf-form4_157437900344256.xml · nonDerivative · entry 1 Talasaz AmirAli · CIK 0001753159 · Director · Chairman, President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,321 Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 17:41 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 10,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001628280-19-013726 · wf-form4_157316645910941.xml · derivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,833 Underlying: COMMON STOCK · 10,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 17:41 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 3,716 | $70.86 | $263,315.76 |
DisclosureSEC source: 0001628280-19-013726 · wf-form4_157316645910941.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.72 to $71.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 17:41 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 2,004 | $69.62 | $139,518.48 |
DisclosureSEC source: 0001628280-19-013726 · wf-form4_157316645910941.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,018 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.23 to $70.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 17:41 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,280 | $68.58 | $293,522.40 |
DisclosureSEC source: 0001628280-19-013726 · wf-form4_157316645910941.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,022 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.21 to $69.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2019 Filed Nov 7, 2019 17:41 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 10,000 | $5.94 | $59,400.00 |
DisclosureSEC source: 0001628280-19-013726 · wf-form4_157316645910941.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 04, 2019 Filed Nov 7, 2019 01:21 UTC |
CLARK IAN TDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 2,690 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001628280-19-013568 · wf-form4_157308968324681.xml · derivative · entry 3 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,659 Underlying: COMMON STOCK · 2,690 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on January 3, 2017. Read SEC document |
| November 04, 2019 Filed Nov 7, 2019 01:21 UTC |
CLARK IAN TDirector
|
SaleCOMMON STOCK | 2,690 | $71.82 | $193,195.80 |
DisclosureSEC source: 0001628280-19-013568 · wf-form4_157308968324681.xml · nonDerivative · entry 2 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. Read SEC document |
| November 04, 2019 Filed Nov 7, 2019 01:21 UTC |
CLARK IAN TDirector
|
Exercise / conversionCOMMON STOCK | 2,690 | $4.18 | $11,244.20 |
DisclosureSEC source: 0001628280-19-013568 · wf-form4_157308968324681.xml · nonDerivative · entry 1 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,992 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 16:58 UTC |
Lanman Richard B.Chief Medical Officer
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 3,459 | $0.00 Strike: $8.80 | $0.00 |
DisclosureSEC source: 0001628280-19-013353 · wf-form4_157299112194362.xml · derivative · entry 5 Lanman Richard B. · CIK 0001721003 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,196 Underlying: COMMON STOCK · 3,459 shares Expires 2028-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 16:58 UTC |
Lanman Richard B.Chief Medical Officer
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 2,305 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001628280-19-013353 · wf-form4_157299112194362.xml · derivative · entry 4 Lanman Richard B. · CIK 0001721003 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,066 Underlying: COMMON STOCK · 2,305 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 1, 2017. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 16:58 UTC |
Lanman Richard B.Chief Medical Officer
|
SaleCOMMON STOCK | 5,764 | $69.96 | $403,249.44 |
DisclosureSEC source: 0001628280-19-013353 · wf-form4_157299112194362.xml · nonDerivative · entry 3 Lanman Richard B. · CIK 0001721003 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,015 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of one or more stock options at an exercise price of $4.18 or $8.80 per share. F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.62 to $70.34. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 16:58 UTC |
Lanman Richard B.Chief Medical Officer
|
Exercise / conversionCOMMON STOCK | 3,459 | $8.80 | $30,439.20 |
DisclosureSEC source: 0001628280-19-013353 · wf-form4_157299112194362.xml · nonDerivative · entry 2 Lanman Richard B. · CIK 0001721003 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,779 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 16:58 UTC |
Lanman Richard B.Chief Medical Officer
|
Exercise / conversionCOMMON STOCK | 2,305 | $4.18 | $9,634.90 |
DisclosureSEC source: 0001628280-19-013353 · wf-form4_157299112194362.xml · nonDerivative · entry 1 Lanman Richard B. · CIK 0001721003 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,320 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 16:36 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 10,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001628280-19-012833 · wf-form4_157246779503500.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,833 Underlying: COMMON STOCK · 10,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 16:36 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 10,000 | $70.34 | $703,400.00 |
DisclosureSEC source: 0001628280-19-012833 · wf-form4_157246779503500.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $5.94 per share. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.88 to $70.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 16:36 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 10,000 | $5.94 | $59,400.00 |
DisclosureSEC source: 0001628280-19-012833 · wf-form4_157246779503500.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,302 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 00:15 UTC |
CLARK IAN TDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 538 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001628280-19-012709 · wf-form4_157239449897742.xml · derivative · entry 4 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,912 Underlying: COMMON STOCK · 538 shares Expires 2027-11-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on October 25, 2017. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 00:15 UTC |
CLARK IAN TDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 2,690 | $0.00 Strike: $4.18 | $0.00 |
DisclosureSEC source: 0001628280-19-012709 · wf-form4_157239449897742.xml · derivative · entry 3 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,349 Underlying: COMMON STOCK · 2,690 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on January 3, 2017. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 00:15 UTC |
CLARK IAN TDirector
|
SaleCOMMON STOCK | 3,228 | $70.00 | $225,960.00 |
DisclosureSEC source: 0001628280-19-012709 · wf-form4_157239449897742.xml · nonDerivative · entry 2 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,302 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share. Read SEC document |
| October 28, 2019 Filed Oct 30, 2019 00:15 UTC |
CLARK IAN TDirector
|
Exercise / conversionCOMMON STOCK | 3,228 | $4.18 | $13,493.04 |
DisclosureSEC source: 0001628280-19-012709 · wf-form4_157239449897742.xml · nonDerivative · entry 1 CLARK IAN T · CIK 0001336504 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 18:45 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 10,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001628280-19-012545 · wf-form4_157195702382668.xml · derivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,833 Underlying: COMMON STOCK · 10,000 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.